Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 436

1.

Pathobiont release from dysbiotic gut microbiota biofilms in intestinal inflammatory diseases: a role for iron?

Buret AG, Motta JP, Allain T, Ferraz J, Wallace JL.

J Biomed Sci. 2019 Jan 3;26(1):1. doi: 10.1186/s12929-018-0495-4. Review.

2.

Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Wallace JL.

Br J Pharmacol. 2019 Jan;176(2):147-154. doi: 10.1111/bph.14527. Epub 2018 Dec 3. Review.

PMID:
30357812
3.

Iron Sequestration in Microbiota Biofilms As A Novel Strategy for Treating Inflammatory Bowel Disease.

Motta JP, Allain T, Green-Harrison LE, Groves RA, Feener T, Ramay H, Beck PL, Lewis IA, Wallace JL, Buret AG.

Inflamm Bowel Dis. 2018 Jun 8;24(7):1493-1502. doi: 10.1093/ibd/izy116.

PMID:
29788224
4.

Eicosanoids in the gastrointestinal tract.

Wallace JL.

Br J Pharmacol. 2018 Feb 27. doi: 10.1111/bph.14178. [Epub ahead of print] Review.

PMID:
29485681
5.

Development and Refinement of Functional Properties of Adult-Born Neurons.

Wallace JL, Wienisch M, Murthy VN.

Neuron. 2018 Feb 7;97(3):727. doi: 10.1016/j.neuron.2018.01.043. No abstract available.

6.
7.

Anti-inflammatory effect of ATB-352, a H2S -releasing ketoprofen derivative, on lipopolysaccharide-induced periodontitis in rats.

Gugliandolo E, Fusco R, D'Amico R, Militi A, Oteri G, Wallace JL, Di Paola R, Cuzzocrea S.

Pharmacol Res. 2018 Jun;132:220-231. doi: 10.1016/j.phrs.2017.12.022. Epub 2017 Dec 26.

PMID:
29287688
8.

Development and Refinement of Functional Properties of Adult-Born Neurons.

Wallace JL, Wienisch M, Murthy VN.

Neuron. 2017 Nov 15;96(4):883-896.e7. doi: 10.1016/j.neuron.2017.09.039. Epub 2017 Oct 19. Erratum in: Neuron. 2018 Feb 7;97(3):727.

9.

Hydrogen sulfide: an agent of stability at the microbiome-mucosa interface.

Wallace JL, Motta JP, Buret AG.

Am J Physiol Gastrointest Liver Physiol. 2018 Feb 1;314(2):G143-G149. doi: 10.1152/ajpgi.00249.2017. Epub 2017 Oct 12.

10.

Gaseous Mediators in Gastrointestinal Mucosal Defense and Injury.

Wallace JL, Ianaro A, de Nucci G.

Dig Dis Sci. 2017 Sep;62(9):2223-2230. doi: 10.1007/s10620-017-4681-0. Epub 2017 Jul 21. Review.

PMID:
28733867
11.

Giardia co-infection promotes the secretion of antimicrobial peptides beta-defensin 2 and trefoil factor 3 and attenuates attaching and effacing bacteria-induced intestinal disease.

Manko A, Motta JP, Cotton JA, Feener T, Oyeyemi A, Vallance BA, Wallace JL, Buret AG.

PLoS One. 2017 Jun 16;12(6):e0178647. doi: 10.1371/journal.pone.0178647. eCollection 2017.

12.

Hydrogen Sulfide-Releasing Therapeutics: Translation to the Clinic.

Wallace JL, Vaughan D, Dicay M, MacNaughton WK, de Nucci G.

Antioxid Redox Signal. 2018 Jun 1;28(16):1533-1540. doi: 10.1089/ars.2017.7068. Epub 2017 May 15.

PMID:
28388861
13.

Giardia duodenalis induces pathogenic dysbiosis of human intestinal microbiota biofilms.

Beatty JK, Akierman SV, Motta JP, Muise S, Workentine ML, Harrison JJ, Bhargava A, Beck PL, Rioux KP, McKnight GW, Wallace JL, Buret AG.

Int J Parasitol. 2017 May;47(6):311-326. doi: 10.1016/j.ijpara.2016.11.010. Epub 2017 Feb 22.

14.

[TRENDS IN DEVELOPMENT OF GI-SAFE ANTI-INFLAMMATORY DRUGS].

Sulaieva ON, Wallace JL.

Klin Med (Mosk). 2017;95(3):222-7. Review. Russian.

PMID:
30303341
15.

Monitoring of Urate-Lowering Therapy Among US Veterans Following the 2012 American College of Rheumatology Guidelines for Management of Gout.

Hughes JC, Wallace JL, Bryant CL, Salvig BE, Fourakre TN, Stone WJ.

Ann Pharmacother. 2017 Apr;51(4):301-306. doi: 10.1177/1060028016679848. Epub 2016 Nov 24.

PMID:
27881692
16.

Modifying the risk of recurrent preterm birth: influence of trimester-specific changes in smoking behaviors.

Wallace JL, Aland KL, Blatt K, Moore E, DeFranco EA.

Am J Obstet Gynecol. 2017 Mar;216(3):310.e1-310.e8. doi: 10.1016/j.ajog.2016.11.1034. Epub 2016 Nov 18.

PMID:
27871837
17.

ATB-346, a novel hydrogen sulfide-releasing anti-inflammatory drug, induces apoptosis of human melanoma cells and inhibits melanoma development in vivo.

De Cicco P, Panza E, Ercolano G, Armogida C, Sessa G, Pirozzi G, Cirino G, Wallace JL, Ianaro A.

Pharmacol Res. 2016 Dec;114:67-73. doi: 10.1016/j.phrs.2016.10.019. Epub 2016 Oct 21.

PMID:
27777130
18.

Hydrogen sulfide-releasing anti-inflammatory drugs for chemoprevention and treatment of cancer.

Ianaro A, Cirino G, Wallace JL.

Pharmacol Res. 2016 Sep;111:652-658. doi: 10.1016/j.phrs.2016.07.041. Epub 2016 Jul 27. Review.

PMID:
27475881
19.

Rebamipide does not protect against naproxen-induced gastric damage: a randomized double-blind controlled trial.

Gagliano-Jucá T, Moreno RA, Zaminelli T, Napolitano M, Magalhães AF, Carvalhaes A, Trevisan MS, Wallace JL, De Nucci G.

BMC Gastroenterol. 2016 Jun 4;16(1):58. doi: 10.1186/s12876-016-0472-x.

20.

Glyprolines exert protective and repair-promoting effects in the rat stomach: potential role of the cytokine GRO/CINC-1.

Bakaeva ZV, Sangadzhieva AD, Tani S, Myasoedov NF, Andreeva LA, Torshin VI, Wallace JL, Tanaka T.

J Physiol Pharmacol. 2016 Apr;67(2):253-60.

21.

Profound Chemopreventative Effects of a Hydrogen Sulfide-Releasing NSAID in the APCMin/+ Mouse Model of Intestinal Tumorigenesis.

Paul-Clark M, Elsheikh W, Kirkby N, Chan M, Devchand P, Agbor TA, Flannigan KL, Cheadle C, Freydin M, Ianaro A, Mitchell JA, Wallace JL.

PLoS One. 2016 Feb 24;11(2):e0147289. doi: 10.1371/journal.pone.0147289. eCollection 2016.

22.

Systematic study of constitutive cyclooxygenase-2 expression: Role of NF-κB and NFAT transcriptional pathways.

Kirkby NS, Chan MV, Zaiss AK, Garcia-Vaz E, Jiao J, Berglund LM, Verdu EF, Ahmetaj-Shala B, Wallace JL, Herschman HR, Gomez MF, Mitchell JA.

Proc Natl Acad Sci U S A. 2016 Jan 12;113(2):434-9. doi: 10.1073/pnas.1517642113. Epub 2015 Dec 28.

23.

Effect of diseases on response to vitamin K antagonists.

Self TH, Owens RE, Sakaan SA, Wallace JL, Sands CW, Howard-Thompson A.

Curr Med Res Opin. 2016;32(4):613-20. doi: 10.1185/03007995.2015.1134464. Epub 2016 Jan 25. Review.

PMID:
26695107
24.

Prevention of NSAID-Enteropathy: A Soluble Problem?

Wallace JL.

Dig Dis Sci. 2016 Jan;61(1):1-3. doi: 10.1007/s10620-015-3963-7. No abstract available.

PMID:
26576552
25.

Effect of Body Weight on Dose of Vitamin K Antagonists.

Self TH, Wallace JL, Sakaan S, Sands CW.

South Med J. 2015 Oct;108(10):637-43. doi: 10.14423/SMJ.0000000000000356. Review.

PMID:
26437201
26.

Gaseous mediator-based anti-inflammatory drugs.

Sulaieva O, Wallace JL.

Curr Opin Pharmacol. 2015 Dec;25:1-6. doi: 10.1016/j.coph.2015.08.005. Epub 2015 Aug 28. Review.

PMID:
26319186
27.

Toward More GI-Friendly Anti-Inflammatory Medications.

Wallace JL, de Nucci G, Sulaieva O.

Curr Treat Options Gastroenterol. 2015 Dec;13(4):377-85. doi: 10.1007/s11938-015-0064-9.

PMID:
26303996
28.

Gaseous mediators in resolution of inflammation.

Wallace JL, Ianaro A, Flannigan KL, Cirino G.

Semin Immunol. 2015 May;27(3):227-33. doi: 10.1016/j.smim.2015.05.004. Epub 2015 Jun 18. Review.

PMID:
26095908
29.

Hydrogen sulfide-based anti-inflammatory and chemopreventive therapies: an experimental approach.

Flannigan KL, Wallace JL.

Curr Pharm Des. 2015;21(21):3012-22. Review.

PMID:
26004409
30.

Deciphering the pathogenesis of NSAID enteropathy using proton pump inhibitors and a hydrogen sulfide-releasing NSAID.

Blackler RW, De Palma G, Manko A, Da Silva GJ, Flannigan KL, Bercik P, Surette MG, Buret AG, Wallace JL.

Am J Physiol Gastrointest Liver Physiol. 2015 Jun 15;308(12):G994-1003.

31.

Hydrogen sulfide-based therapeutics: exploiting a unique but ubiquitous gasotransmitter.

Wallace JL, Wang R.

Nat Rev Drug Discov. 2015 May;14(5):329-45. doi: 10.1038/nrd4433. Epub 2015 Apr 7. Review.

PMID:
25849904
32.

Endogenous prostaglandins and afferent sensory nerves in gastroprotective effect of hydrogen sulfide against stress-induced gastric lesions.

Magierowski M, Jasnos K, Kwiecien S, Drozdowicz D, Surmiak M, Strzalka M, Ptak-Belowska A, Wallace JL, Brzozowski T.

PLoS One. 2015 Mar 16;10(3):e0118972. doi: 10.1371/journal.pone.0118972. eCollection 2015.

33.

The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis.

Herrera BS, Coimbra LS, da Silva AR, Teixeira SA, Costa SK, Wallace JL, Spolidorio LC, Muscara MN.

Med Gas Res. 2015 Feb 27;5:4. doi: 10.1186/s13618-015-0025-3. eCollection 2015.

34.

Anti-inflammatory and cytoprotective properties of hydrogen sulfide.

Gemici B, Wallace JL.

Methods Enzymol. 2015;555:169-93. doi: 10.1016/bs.mie.2014.11.034. Epub 2015 Jan 8.

PMID:
25747480
35.

Hydrogen sulfide protects from colitis and restores intestinal microbiota biofilm and mucus production.

Motta JP, Flannigan KL, Agbor TA, Beatty JK, Blackler RW, Workentine ML, Da Silva GJ, Wang R, Buret AG, Wallace JL.

Inflamm Bowel Dis. 2015 May;21(5):1006-17. doi: 10.1097/MIB.0000000000000345.

PMID:
25738373
36.

Exposure to non-steroid anti-inflammatory drugs (NSAIDs) and suppressing hydrogen sulfide synthesis leads to altered structure and impaired function of the oesophagus and oesophagogastric junction.

Zayachkivska O, Bula N, Khyrivska D, Gavrilyuk E, Wallace JL.

Inflammopharmacology. 2015 Jun;23(2-3):91-9. doi: 10.1007/s10787-015-0230-7. Epub 2015 Feb 25.

PMID:
25711289
37.

NSAID enteropathy and bacteria: a complicated relationship.

Syer SD, Blackler RW, Martin R, de Palma G, Rossi L, Verdu E, Bercik P, Surette MG, Aucouturier A, Langella P, Wallace JL.

J Gastroenterol. 2015 Apr;50(4):387-93. doi: 10.1007/s00535-014-1032-1. Epub 2015 Jan 10. Review.

PMID:
25572030
38.

Proresolution effects of hydrogen sulfide during colitis are mediated through hypoxia-inducible factor-1α.

Flannigan KL, Agbor TA, Motta JP, Ferraz JG, Wang R, Buret AG, Wallace JL.

FASEB J. 2015 Apr;29(4):1591-602. doi: 10.1096/fj.14-266015. Epub 2014 Dec 30.

PMID:
25550470
39.

Hydrogen sulfide-releasing cyclooxygenase inhibitor ATB-346 enhances motor function and reduces cortical lesion volume following traumatic brain injury in mice.

Campolo M, Esposito E, Ahmad A, Di Paola R, Paterniti I, Cordaro M, Bruschetta G, Wallace JL, Cuzzocrea S.

J Neuroinflammation. 2014 Dec 4;11:196. doi: 10.1186/s12974-014-0196-1.

40.

H2S-releasing drugs: anti-inflammatory, cytoprotective and chemopreventative potential.

Gemici B, Elsheikh W, Feitosa KB, Costa SK, Muscara MN, Wallace JL.

Nitric Oxide. 2015 Apr 30;46:25-31. doi: 10.1016/j.niox.2014.11.010. Epub 2014 Nov 18. Review.

PMID:
25461269
41.

Cytoprotective effects of hydrogen sulfide in novel rat models of non-erosive esophagitis.

Zayachkivska O, Havryluk O, Hrycevych N, Bula N, Grushka O, Wallace JL.

PLoS One. 2014 Oct 21;9(10):e110688. doi: 10.1371/journal.pone.0110688. eCollection 2014.

42.

Hydrogen sulphide protects against NSAID-enteropathy through modulation of bile and the microbiota.

Blackler RW, Motta JP, Manko A, Workentine M, Bercik P, Surette MG, Wallace JL.

Br J Pharmacol. 2015 Feb;172(4):992-1004. doi: 10.1111/bph.12961. Epub 2014 Nov 24.

43.

Effects of conventional and hydrogen sulfide-releasing non-steroidal anti-inflammatory drugs in rats with stress-induced and epinephrine-induced gastric damage.

Fomenko I, Sklyarov A, Bondarchuk T, Biletska L, Panasyuk N, Wallace JL.

Stress. 2014 Dec;17(6):528-37. doi: 10.3109/10253890.2014.967207.

PMID:
25238023
44.

Impaired hydrogen sulfide synthesis and IL-10 signaling underlie hyperhomocysteinemia-associated exacerbation of colitis.

Flannigan KL, Agbor TA, Blackler RW, Kim JJ, Khan WI, Verdu EF, Ferraz JG, Wallace JL.

Proc Natl Acad Sci U S A. 2014 Sep 16;111(37):13559-64. doi: 10.1073/pnas.1413390111. Epub 2014 Sep 3.

45.

Exploiting endogenous anti-inflammatory pathways as a therapeutic approach to multiorgan inflammatory disease.

Wallace JL.

Am J Pathol. 2014 Aug;184(8):2154-5. doi: 10.1016/j.ajpath.2014.05.001. Epub 2014 Jul 10.

PMID:
25016432
46.

NSAID-gastroenteropathy: new aspects of pathogenesis and prevention.

Blackler RW, Gemici B, Manko A, Wallace JL.

Curr Opin Pharmacol. 2014 Dec;19:11-6. doi: 10.1016/j.coph.2014.05.008. Epub 2014 Jun 13. Review.

PMID:
24929967
47.

Interactions of hydrogen sulfide with myeloperoxidase.

Pálinkás Z, Furtmüller PG, Nagy A, Jakopitsch C, Pirker KF, Magierowski M, Jasnos K, Wallace JL, Obinger C, Nagy P.

Br J Pharmacol. 2015 Mar;172(6):1516-32. doi: 10.1111/bph.12769. Epub 2014 Sep 5.

48.

Enhanced chemopreventive effects of a hydrogen sulfide-releasing anti-inflammatory drug (ATB-346) in experimental colorectal cancer.

Elsheikh W, Blackler RW, Flannigan KL, Wallace JL.

Nitric Oxide. 2014 Sep 15;41:131-7. doi: 10.1016/j.niox.2014.04.006. Epub 2014 Apr 18.

PMID:
24747869
49.

Incorrect use of peak flow meters: are you observing your patients?

Self TH, George CM, Wallace JL, Patterson SJ, Finch CK.

J Asthma. 2014 Aug;51(6):566-72. doi: 10.3109/02770903.2014.914218. Epub 2014 May 9. Review.

PMID:
24720711
50.

Anti-inflammatory and cytoprotective actions of hydrogen sulfide: translation to therapeutics.

Wallace JL, Blackler RW, Chan MV, Da Silva GJ, Elsheikh W, Flannigan KL, Gamaniek I, Manko A, Wang L, Motta JP, Buret AG.

Antioxid Redox Signal. 2015 Feb 10;22(5):398-410. doi: 10.1089/ars.2014.5901. Epub 2014 Apr 15. Review.

PMID:
24635322

Supplemental Content

Loading ...
Support Center